Columbia Analytical Services Implements New USP Guidelines
(Kelso, Washington; November 10, 2010) - Columbia Analytical Services is pleased to announce its implementation of heavy metals testing that follows new recommendations released by the United States Pharmacopeia (USP). Columbia Analytical’s Pharmaceutical Division, a registered analytical laboratory providing current Good Manufacturing Practice (cGMP) compliant testing, abides by newly released instrumental methods guidelines for the detection of elemental impurities by Inductively Coupled Plasma-Mass Spectroscopy (ICP-MS).
The USP recently proposed toxicological limits for elemental impurities to produce reliable data at detection levels that easily meet the elemental impurity limits. Experts at Columbia Analytical have extensive experience analyzing metals in a wide variety of matrices. Instrumental methods provided by Columbia Analytical accurately detect if metals meet or exceed those limits.
Columbia Analytical will be exhibiting at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, which will take place November 14-18, 2010, in New Orleans, Louisiana, at the Morial Convention Center, booth #2605.
“We are thrilled to join the thousands of scientists converging at the AAPS Annual Meeting this year, sharing their various perspectives and ideas, all with the goal in mind to improve overall health through advancing pharmaceutical sciences,” stated Jeff Grindstaff, Columbia Analytical laboratory director. “We are excited to showcase our capabilities, especially our wide-spread expertise in the detection of impurities in heavy metals.”
Columbia Analytical provides pharmaceutical testing and presents sound, accurate and reliable data, coupled with excellent customer service. In addition to its heavy metals testing, Columbia Analytical’s comprehensive range of capabilities includes monograph testing, method development and validation, engineering studies, process validation and stability testing.
About Columbia Analytical Services, Pharmaceutical Division
Columbia Analytical Services, Inc., Pharmaceutical Division is a registered contract testing laboratory providing cGMP-compliant testing to the raw material suppliers, CMOs, and product developers/sponsors of the pharmaceutical industry. To ensure regulatory compliance, Columbia Analytical is FDA inspected and registered, and DEA licensed. Columbia Analytical professional scientists have extensive experience in analytical chemistry and routinely provide method development and validation for pharmaceutical testing. For more information about Columbia Analytical Pharmaceutical Division, visit www.caspharma.com.